Keynote oncology clinical trials

What’s Keynote oncology clinical trials

Keynote oncology clinical trials is a series of clinical trials to determine whether an investigational immunotherapy may help in the treatment of cancer. The investigational immunotherapy is pembrolizumab (MK-3475).

We have investigational clinical trials under way or planned in multiple cancer types. We are currently studying the types of cancer listed below. We encourage you to speak with your physician to determine if a Keynote clinical trial may be right for you.

也就是说这个项目主要是针对肿瘤免疫治疗的, 并且不区分癌症种类。

Our Keynote clinical trials are studying a way to treat cancer through immunotherapy-which may help the body’s immune system fight cancer. The investigational immunotherapy used in the Keynote Trials is pembrolizumab, also known as MK-3475, a PD-1 blocking antibody.

Oncology immunotherapy is a type of cancer treatment designed to work with the body’s natural defenses to fight the cancer. These treatments are engineered to allow your immune system to help recognize harmful tumor cells and destroy them.

Keynote – Breast cancer


Pursuing the dream and the best future

CHENYUAN Blog Homepage

因为不想遗忘! 在这个信息大爆炸的年代,最重要的是对知识的消化-吸收-重铸。每天学了很多东西,但是理解的多少,以及能够运用多少是日后成功的关键。作为一个PhD,大脑中充斥了太多的东西,同时随着年龄的增长,难免会忘掉很多事情。所以只是为了在众多教程中写一个自己用到的,与自己...… Continue reading